Gammopathy pp 177-198 | Cite as

Forms and differentiation of the plasma cell tumors

  • János Jákó


Autonomic irreversible proliferation of the cells that produce immunoglobulins of different specificity is termed plasma cell tumor. Such tumors either infiltrate the bone marrow, or form isolated islets; combined forms also occur.


Multiple Myeloma Plasma Cell Plasma Cell Leukemia Surface Immunoglobulin Extramedullary Plasmacytoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abdou, N. I., Abdou, N. L. The monoclonal nature of lymphocytes in multiplex myeloma. Ann. intern. Med. 83, 42. 1975.PubMedGoogle Scholar
  2. 2.
    Ackerman, L. V., Spjut, H. J. Tumors of bone and cartilage. In: Atlas of Tumor Pathology. Armed Forces Institute of Pathology. Washington, D. C. 152. 1962.Google Scholar
  3. 3.
    Alexanian, R. Monoclonal gammopathy in lymphoma. Arch. intern. Med. 135, 62. 1975.PubMedCrossRefGoogle Scholar
  4. 4.
    Alexanian, R., Balcerzak, S., Bonnet, J. D., Gehan, E. A., Haut, A., Hewlett, J. S., Monto, R. W. Prognostic factors in multiple myeloma. Cancer. 36, 1192. 1975.PubMedCrossRefGoogle Scholar
  5. 5.
    Alexanian, R., Gehan, E., Hant, A., Saiki, J., Weick, J. Unmaintained remissions in multiple myeloma. Blood.51, 1005. 1978.PubMedGoogle Scholar
  6. 6.
    Andaloro, V. A. Jr., Baboll, D. Testicular involvement in plasma-cell leukemia. Urology. 3, 636. 1974.PubMedCrossRefGoogle Scholar
  7. 7.
    Anderson, P. E. Extramedullary plasmocytomas. Acta Radiol. 32, 365. 1949.CrossRefGoogle Scholar
  8. 8.
    Ash, J. E., Beck, M. R., Wilkes, J. D. Tumors of the upper respiratory tract and ear. In: Atlas of Tumor Pathology. Armed Forces Institute of Pathology. Washington, D. C., 150. 1964.Google Scholar
  9. 9.
    Azar, H. A., Hill, W. T., Ossermann, E. F. Malignant lymphoma and lymphocytic leukaemia associated with myeloma type serum proteins. Amer. J. Med. 23, 239. 1957.PubMedCrossRefGoogle Scholar
  10. 10.
    Barlogie, B., Gohde, W., Johnston, D. A., Smallwood, L., Schumann, J., Drewinko, B. Determination of ploidy and proliferative characteristics of human solid tumors by pulse cytophotometry. Cancer Research. 39, 3333. 1978.Google Scholar
  11. 11.
    Barlogie, B., Latreille, J., Freireich, E. J., Fu, C. T., Mellard, D., Meistrich, M., Andreeff, M. Characterization of hematologic malignancies by flow cytometry. Blood Cells. 6, 719, 1980.PubMedGoogle Scholar
  12. 12.
    Barlogie, B., Alexanian, R., Gehan, E. A., Smallwood, L., Smith, T., Drewinko, B. Marrow cytometry and prognosis in myeloma. J. Clin. Invest. 72, 853. 1983.PubMedCrossRefGoogle Scholar
  13. 13.
    Barlogie, B., Maddox, A. M., Johnston, D. A., Raber, M. N., Drewinko, B., Keating, M. J., Freireich, E. J. Quantitative cytology in leukemia research. Blood Cells. 9, 35. 1983.PubMedGoogle Scholar
  14. 14.
    Barlogie, B., Raber, M. N., Schumann, J., Johnson, T. S., Drewinko, B., Swartzendruber, D. E., Gohde, W, Andreeff, M, Freireich, E. J. Perspectives in cancer research, flow cytometry in clinical cancer research. Cancer Research. 43, 3982. 1983.PubMedGoogle Scholar
  15. 15.
    Barlogie, B., Alexanian, R., Pershouse, M., Smallwood, L., Smith, L. Cytoplasmic immunoglobulin content in multiple myeloma. J. Clin Invest. 76, 765. 1984.CrossRefGoogle Scholar
  16. 16.
    Barlogie, B., Alexanian, R., Smith, L., Dixon, D., Smallwood, L., Delasalle, K. Prognostic implications of tumour cell DNA and RNA content in multiple myeloma. Blood. 66, 335. 1985.Google Scholar
  17. 17.
    Bartl, R., Frisch, B., Burkhardt, R., Fateh-Moghadam, A., Mahl. G., Gierster, P., Sund, M., Kettner, G. Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging. Brit, J. Haematol. 51, 361. 1982.CrossRefGoogle Scholar
  18. 18.
    Bataille, R., Grenier, J., Sany, J. Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment — a prospective study of 160 patients. Blood. 63, 468. 1984.PubMedGoogle Scholar
  19. 19.
    Batsakis, J. G., Faries, G. T., Goldman, R. T., Arlsberg, R. C. Upper respiratory tract plasmacytoma. Arch. Otolaryngol. 79, 613. 1964.PubMedCrossRefGoogle Scholar
  20. 20.
    Bergsagel, D. E., Kyle, R., Bataille, R. Plasma cell neoplasms. International Congress ISH-ISBT. Budapest. 1,7. 1982.Google Scholar
  21. 21.
    Bernard, A., Boumsell, L., Dausset, J., Milstein, C., Schlossman, S. F. Leucocyte Typing. Springer-Verlag. Berlin. 1, 814. 1984.Google Scholar
  22. 22.
    Bichel, J., Kirketerp, P. Notes on myeloma. Acta Radiol. 19, 487. 1983.Google Scholar
  23. 23.
    Bodó, M., Petõ, I., Sas, G., Juhász, J. Reticulosarcomatous transformation of a primary recurrent gastric plasmocytoma. Haematologia. 10, 213. 1976.PubMedGoogle Scholar
  24. 24.
    Bösken, W., Noltenius, H. Grosszelliges Reticulumzellsarkom als Spätzustand einer endoxanbehandelten Makroglobulinaemie Waldenström. Zbl. aellg. Path. 111, 407. 1968.Google Scholar
  25. 25.
    Caligaris-Cappio, F., Bergui, L., Tesio, L., Pizzolo, G., Malavasi, F., Chilosi, M., Campana, D., van Camp, B., Jánossy, G. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. J. Clin. Invest. 76, 1243. 1985.PubMedCrossRefGoogle Scholar
  26. 26.
    Carbone, P. P., Kellerhouse, L. E., Gehan, E. A. Plasmacytic myeloma. A study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients. Amer. J. Med. 42, 937. 1967.PubMedCrossRefGoogle Scholar
  27. 27.
    Carson, C. P., Ackerman, L. V., Maltby, J. D. Plasma cell myeloma. A clinical pathologic and roentgenologic review of 90 cases. Amer. J. clin. Path. 25, 849. 1955.Google Scholar
  28. 28.
    Christopherson, W. M., Miller, A. J. A re-evaluation of solitary plasma-cell myeloma of bone. Cancer. 3, 240. 1950.CrossRefGoogle Scholar
  29. 29.
    Churg, J., Gordon, A. J. Multiple myeloma. Lesions of the extra-osseous hematopoietic system. Amer. J. Clin. Path. 20, 934. 1950.Google Scholar
  30. 30.
    Colls, B. M., Lorier, M. A. Immunocytoma, cancer and other associations of monoclonal gammopathy: a review of 224 cases. New Zealand Med. 7, 82. 1975.Google Scholar
  31. 31.
    Custer, R. P., Bernhard, W. G. Interrelationship of Hodgkin’s disease and other lymphatic tumors. Amer. J. med. Sci. 216, 625. 1948.PubMedCrossRefGoogle Scholar
  32. 32.
    Cutler, M., Buchke, F., Cantril, S. T. Course of single myeloma of bone: Report of 20 cases. Surg. Gynecol. Obstet. 62, 918. 1936.Google Scholar
  33. 33.
    Dao, C., Zittovn, R., Diebold, J., Cadiou, M., Reyner, M., Gandric, M., Tricot, G., Bousser, J. Formes sarcomateuses et leukemiques de la macroglobulinémie de Waldenström. Sem. Hop. Paris. 51, 2935. 1975.PubMedGoogle Scholar
  34. 34.
    Dolin, S., Dewar, J. P. Extramedullary plasmocytoma. Amer. J. Path. 32, 82. 1956.Google Scholar
  35. 35.
    Downey, H. Handbook of Haematology. Ed: Hoeber, P. B. New York. 2, 1438. 1938.Google Scholar
  36. 36.
    Durie, B. G. M., Salmon, S. E. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 36, 842. 1975.PubMedCrossRefGoogle Scholar
  37. 37.
    Durie, B. G. M., Salmon, S. E., Moon, T. E. Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma. Blood. 55, 364. 1980.PubMedGoogle Scholar
  38. 38.
    Durie, B. G. M., Grogan, T. M. CALLA-positive myeloma: an agressive subtype with poor survival. Blood. 66, 229. 1985.PubMedGoogle Scholar
  39. 39.
    Durrant, J. R., Barry, W. E., Learner, N. The changing face of myeloma. Lancet. i, 119. 1966.CrossRefGoogle Scholar
  40. 40.
    Ewing, M. R., Fotte, F. W. Jr. Plasma-cell tumours of mouth and upper air passages. Cancer. 5, 499. 1952.PubMedCrossRefGoogle Scholar
  41. 41.
    Farrer-Brown, G. „A classification of the non-Hodgkin’s lymphomas”. XI. Internat. Congr. Internat. Acad. Path. Washington, D. C. 80. 1976.Google Scholar
  42. 42.
    Frangione, B., Franklin, E. C. Heavy chain diseases: clinical features and molecular Significance of the disordered immunoglobulin structure. Semin. Hematol. 10, 53. 1973.PubMedGoogle Scholar
  43. 43.
    Frizzera, G., Moran, E. M., Rappaport, H. Angio-immunoblastic lymphadenopathy with dysproteinaemia. Lancet, ii, 1070. 1974.CrossRefGoogle Scholar
  44. 44.
    Gassmann, W., Pralle, H., Haferlach, T., Pandurevic, S., Graubner, M., Schmitz, N., Löffler, H. Staging systems for multiple myeloma: a comparison. Brit. J. Haematol. 59, 703. 1985.CrossRefGoogle Scholar
  45. 45.
    Givler, R. Lymphocytic leukemia with coexistent localized reticulum cell sarcoma. Cancer. 21, 1184. 1968.PubMedCrossRefGoogle Scholar
  46. 46.
    Gonzalez, F., Trujillo, J. M., Alexanian, R. Acute leukemia in multiple myeloma. Ann. intern. Med. 86, 440. 1977.PubMedGoogle Scholar
  47. 47.
    Hallen, J. Frequency of „abnormal” serum globulins (M-components) in the aged. Acta, med. scand. 173, 737. 1963.CrossRefGoogle Scholar
  48. 48.
    Hayes, D. W., Bennett, W. A., Heck, F. J. Extra-medullary lesions in multiple myeloma: review of literature and pathologic studies. Arch. Pathol. 53, 262. 1952.Google Scholar
  49. 49.
    Heller, P., Yakulis, V., Bhoopalam, N., Costea, N., Cabana, V., Nathon, R. D. Surface immunoglobulins on circulating lymphocytes in mouse and human plasmocytoma. Trans. Ass. Amer. Physns. 85, 192. 1972.Google Scholar
  50. 50.
    Helmus, C. Extramedullary plasmacytoma of the head and neck. Laringoscope. 74, 553. 1964.CrossRefGoogle Scholar
  51. 51.
    Hijmans, W., Schuit, H. R. E., Hulsing-Hesselink, E. An immunofluorescence study on intracellular immunoglobulins in human bone marrow cells. Ann. N. Y. Acad. Sci. 177, 920. 1971.Google Scholar
  52. 52.
    Hijmans, W., Schuit, H. R. E. Immunofluorescence studies on immunoglobulins on the lymphoid cells of human peripheral blood. Clin. exp. Immunol. 11, 483, 1972.PubMedGoogle Scholar
  53. 53.
    Hobbs, J. R. Growth rates and responses to treatment in human myelomatosis. Brit, J. Haematol. 16, 607. 1969.CrossRefGoogle Scholar
  54. 54.
    Hobbs, J. R. Monitoring myelomatosis. Arch. Intern. Med. 135, 125. 1975.PubMedCrossRefGoogle Scholar
  55. 55.
    Hofmann, W., Salmon S., Durie, B. G. M. Drug resistance in multiple myeloma associated with high in vitro incorporation of H-thymidine. Blood, 58,471. 1981.PubMedGoogle Scholar
  56. 56.
    Hokanson, J. A., Brown, B. W., Thompson, J. R., Drewinko, B., Alexanian, R. Tumor growth patterns in multiple myeloma. Cancer. 39, 1077. 1977.PubMedCrossRefGoogle Scholar
  57. 57.
    Hollard, D., Müller, J. M., Leger, J. Association myeloma, leucose myeloide et lymphosarcome: Reflexions nosologiques. Lyon, Med. 213, 967. 1965.Google Scholar
  58. 58.
    Holm, G., Mellstedt, H., Petterson, D., Biberfeld, P. Idiotypic immunoglobulin structures on blood lymphocytes in human plasma cell myeloma. Immunol. Rev. 34, 139. 1977.PubMedCrossRefGoogle Scholar
  59. 59.
    Holt, J. M., Robb-Smith, A. H. T. Multiple myeloma: development of plasma cell sarcoma during apparently successful chemotherapy. J. Clin. Pathol. 26, 649. 1973.PubMedCrossRefGoogle Scholar
  60. 60.
    Jákó, J. Die idiopathische monoclonale Gammopathie. Kongress für Laboratoriumsmedizin. Berlin. május 15–19. 1977.Google Scholar
  61. 61.
    Jákó, J., Virág, Sz., Riesz, T., Juhász, J. Plasmoblastoma. Magyar Pathológusok Társasága Nagygyűlése. Szeged. május 25–28. 1977.Google Scholar
  62. 62.
    Keiser, G., Veklinger, E., Virieux, C. 2 cases of chronic lymphatic leukemia and Hodgkins’s disease. Acta Haemat. 26, 29. 1961.PubMedCrossRefGoogle Scholar
  63. 63.
    Klein, E., Eskeland, T., Inove, M., Strom, R., Johannson, B. Surface immunoglobulin — moieties on lymphoid cells. Exp. Cell. Res. 62, 133. 1970.PubMedCrossRefGoogle Scholar
  64. 64.
    Klemm, D., Merker, H., Westerhausen, M. Akute Neuproliferation bei paraproteinaemischen Hämoblastosen unter langdauernder Zytostatikabehandlung. Dtsch. med. Wschr. 43, 2063. 1968.CrossRefGoogle Scholar
  65. 65.
    Knapp, W., Schuit, H. R. E., Bolhuis, R. L. K., Hijmans, W. Surface immunoglobulins in chronic lymphatic leukaemia, macroglobulinaemia and myelomatosis. Clin. exp. Immunol. 16, 541. 1974.Google Scholar
  66. 66.
    Krauss, S., Sokal, J. E. Paraproteinemia in the lymphomas. Amer. J. Med. 40,400. 1966.CrossRefGoogle Scholar
  67. 67.
    Kyle, R. A., Pierre, R. V., Bayrd, E. D. Multiple myeloma and acute myelomonocytic leukemia. N. Engl. J. Med. 283, 1121. 1970.PubMedCrossRefGoogle Scholar
  68. 68.
    Kyle, R. A., Maldonado, J. E., Bayrd, E. D. Plasma cell leukemia: report on 17 cases. Arch. intern. Med. 134, 133. 1974.Google Scholar
  69. 69.
    Kyle, R. A., Pierre, R. V., Bayrd, E. D. Multiple myeloma and acute leukemia associated with alkylating agents. Arch. intern. Med. 135, 185. 1975.PubMedCrossRefGoogle Scholar
  70. 70.
    Kyle, R. A., Bayrd, E. D. The monoclonal gammopathies. Charles C. Thomas. Publisher USA. 148. 1976.Google Scholar
  71. 71.
    Kyle, R.A.,Greipp,P. R. Smoldering multiple myeloma. N. Engl. J. Med. 302, 1347. 1980.PubMedCrossRefGoogle Scholar
  72. 72.
    Labedzki, L., Fuchs, H. J., Grips, H. Multiple myeloma and terminal acute myeloid leukemia. Dtsch. med. Wschr. 101, 108. 1976.PubMedCrossRefGoogle Scholar
  73. 73.
    Latreille, J., Barlogie, B., Dosik, G., Johnston, D. A., Drewinko, B., Alexanian, R. Cellular DNA content as a marker of human multiple myeloma. Blood. 55, 403. 1980.PubMedGoogle Scholar
  74. 74.
    Latreille, J., Barlogie, B., Johnston, D. A., Drewinko, B., Alexanian, R. Ploidy and proliferative characteristics in monoclonal gammopathies. Blood. 59, 43. 1982.PubMedGoogle Scholar
  75. 75.
    Law, I. P. Kaposi sarcoma and plasma cell dyscrasia. J. Amer. Med. Ass. 229, 1329. 1974.CrossRefGoogle Scholar
  76. 76.
    Liang, W., Hopper, J. E., Rowley, J. D. Karyotypic abnormalities and clinical aspects of patients with multiple myeloma and related paraproteinemic disorders. Cancer, 44, 630. 1979.PubMedCrossRefGoogle Scholar
  77. 77.
    Lindström, F. B., Hardy, W. R., Eberle, B. J., Williams, R. C.Jr. Multiple myeloma and benign monoclonal gammopathy: differentation by immunofluorescence of lymphocytes. Ann. intern. Med., 78, 837. 1973.PubMedGoogle Scholar
  78. 78.
    Lortholary, P., Boiron, M., Ripault, P. Leucémie lymphoide chronique secondairement associée à une reticulopathie maligne, syndrome de Richter. Nouv. Rev. franc. Hémat. 4, 621. 1964.Google Scholar
  79. 79.
    Marchal, G., Duhamel, G., Weill-Fage, J. C, Blamoutier, B. Maladie de Hodgkin avec tableau initial de leucémie lymphoide et association de tuberculose. Bull. Soc. Med. hop. Paris. 69, 734. 1953.PubMedGoogle Scholar
  80. 80.
    Mathé, G., Belpomme, D., Dantchev, D., Pouillart, P. Progress in the classification of lymphoid and/or monocytoid leukemias and of lympho- and reticulosarcomas. Biomedicine. 22, 177. 1975.PubMedGoogle Scholar
  81. 81.
    Medical Research Council’s Working Party on Leukaemia in Adults: Prognostic features in the third MRC myelomatosis trial. Brit. J. Cancer. 42, 831. 1980.CrossRefGoogle Scholar
  82. 82.
    Mellstedt, H., Hammarström, S., Holm, G. Monoclonal lymphocyte population in human plasma cell myeloma. Clin. exp. Immunol. 17, 371. 1974.PubMedGoogle Scholar
  83. 83.
    Mellstedt, H., Pettersson, D., Holm, G. Monoclonal B-lymphocytes in peripherial blood of patients with plasma cell myeloma. Scand. J. Haematol. 16, 112. 1976.PubMedCrossRefGoogle Scholar
  84. 84.
    Merlini, G., Waldenström, J. G., Jayakar, S. D. A new improved clinical staging system for multiple myeloma based on analysis of 123 treated patients. Blood. 55, 1011. 1980.PubMedGoogle Scholar
  85. 85.
    Moore, D. F., Migliore, P. S., Schullenberger, C. C., Alexanian, R. Monoclonal macroglobulinemia in malignant lymphoma. Ann. intern. Med. 72, 43. 1970.PubMedGoogle Scholar
  86. 86.
    Naidu, R. I., Rosner, F. Combined multiple myeloma and chronic lymphatic leukemia. N. Engl. J. Med. 284, 108, 1971.PubMedGoogle Scholar
  87. 87.
    Narasimhan, P., Jagathambal, K., Elizalde, A. M., Rosner, F. Chronic lymphocytic leukemia and lymphosarcoma associated with multiple myeloma. Arch. intern. Med. 135, 729. 1975.PubMedCrossRefGoogle Scholar
  88. 88.
    Okano, H., Azar, H. A., Osserman, E. F. Plasmocytic reticulum cell sarcoma. Case report with electron microscopic studies. Amer, J. clin. Path. 46, 546. 1966.Google Scholar
  89. 89.
    Ösby, E., Carlmark, B., Reizenstein, P. Staging of myeloma. A preliminary study of staging factors and treatment in different stages. Recent Results in Cancer Research. Lymphoid Neoplasias. In: II. Clinical and Therapeutic Aspects (Ed. by Mathe, G., Seligman, M., Tubiana, M., Springer, Berlin. 21, 1978.Google Scholar
  90. 90.
    Österberg, G., Rausing, A. Reticulum cell sarcoma in Waldenström’s macroglobulinemia after Chlorambucil treatment. Acta med. scand. 188, 497. 1970.PubMedCrossRefGoogle Scholar
  91. 91.
    Palutke, M., McDonald, J. M. Monoclonal gammopathies associated with malignant lymphomas. Amer. J. Clin. Pathol. 60, 157. 1973.Google Scholar
  92. 92.
    Paul, L. W., Pohle, E. A. Solitary myeloma of bone. Radiol. 35, 651. 1940.Google Scholar
  93. 93.
    Pazmantier, M. W., Azar, H. A. Extraskeletal spread in multiple myeloma. Cancer. 23, 167. 1969.CrossRefGoogle Scholar
  94. 94.
    Pedraza, M. A. Plasma-cell leukemia with unusual immunoglobulin abnormalities. Amer. J. clin. Pathol. 64, 410. 1975.Google Scholar
  95. 95.
    Pennec, Y., Mottier, D., Youinou, P., Asselain, B., Chavance, M., Le Goff, P., Le Prise, P. Y., Miossec, P., Le Menn, G. Critical study of staging in multiple myeloma. Scand. J. Haematol. 30, 183. 1983.PubMedCrossRefGoogle Scholar
  96. 96.
    Pernis, B., Formi, L., Amante, L. Immunoglobulin spots on the surface of rabbit lymphocytes. J. exp. Med. 132, 1001. 1970.PubMedCrossRefGoogle Scholar
  97. 97.
    Pierson, J., Darley, T., Stevenson, G. T., Virji, M. Monoclonal immunoglobulin light chains in urine of patients with lymphoma. Brit. J. Cancer. 41, 681. 1980.PubMedCrossRefGoogle Scholar
  98. 98.
    Polliack, A., Naparsteck, Elizabeth, Eldor, A., Ben Zvi, A., Ben Bassat, H., Zlotnick, A. Multiple myeloma terminating in lymphocytic leukemia with B-lymphocyte membrane markers. Amer. J. Haematol. 3, 153. 1977.Google Scholar
  99. 99.
    Porez-Soler, R., Estebon, R., Allende, E., Tornos-Salomo, C., Julia, A., Quardia, J. Live involvement, in multiple myeloma. Amer. J. Haematol. 20, 25. 1985.CrossRefGoogle Scholar
  100. 100.
    Potter, M. Experimental plasma cell tumors and other immunoglobulin -producing lymphoreticular neoplasms in mice. In: Multiple myeloma and related disorders. Ed: Azar, H. A., Potter, M. Hagerstown, Maryland, Harper and Row Publishers 1, 177. 1973.Google Scholar
  101. 101.
    Preud’homme, J. L., Seligmann, M. Surface-bound immunoglobulins as cell markers in human lymphoproliferative diseases. Blood. 40, 77. 1972.Google Scholar
  102. 102.
    Rabellino, E., Colous, S., Grey, H. M., Unanue, ER. Immunoglobulins on the surface of lymphocytes. I. Distribution and quantitation, J. Exp. Med., 133, 156. 1971.PubMedCrossRefGoogle Scholar
  103. 103.
    Raff, M. C, Sternberg, M., Taylor, R. B. Immunoglobulin determinants on the surface of mouse lymphoid cells. Nature. 225, 553. 1970.PubMedCrossRefGoogle Scholar
  104. 104.
    Ralph, P., Prichard, J., Cohn, M. Reticulum cell sarcoma: an effector cell in antibodydependent cell mediated immunity. J. Immunol. 114, 898. 1975.PubMedGoogle Scholar
  105. 105.
    Rappaport,H. ”Tumors of the hematopoietic system”, In: ”Atlas of tumor pathology” Washington, D. C, AFIP. 1966.Google Scholar
  106. 106.
    Rausing, A.: Lymphatic leukemia and malignant lymphoma in the adult. Acta med. scand. suppl. 595. 1976.Google Scholar
  107. 107.
    Renau-Piqueras, J., Wetter, O., Miragall, F., Miquel, A., Hertenstein, Ch., Cervera, J., Brandhorst, D. Extramedullary multiple myeloma: A qualitative and quantitative electronmicroscopic study. Virchows Arch. (Cell Pathol) 40, 171. 1982.CrossRefGoogle Scholar
  108. 108.
    Riesz, T., Jákó, J., Juhász, J. Second malignant tumors accompanied with primary hepatocellular carcinoma. Acta Hepato-Gastroenterol. 26, 729. 1979.Google Scholar
  109. 109.
    Sacks, P. V., Tavassoli, M., Eastlund, D. T. Simultaneous accurence of myeloma and Hodgkin’s disease. Acta Haematol. 55, 118. 1976.PubMedCrossRefGoogle Scholar
  110. 110.
    Salmon, S. E., Smith, B. Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma. J. Clin. Invest. 49, 1114. 1970.PubMedCrossRefGoogle Scholar
  111. 111.
    Salmon, S. E., McIntyre, O. R., Ogawa, M. IgE myeloma: total body tumor cell number and synthesis of IgE and DNA. Blood. 37, 696. 1971.PubMedGoogle Scholar
  112. 112.
    Salmon, S. E. Immunoglobulin synthesis and tumor kinetics of multiple myeloma. Semin. Hematol. 10, 135. 1973.PubMedGoogle Scholar
  113. 113.
    Salmon, S. E. In vitro cloning and chemosensitivity of human myeloma stem cells. Clinics in Haematology. 11, 47. 1982.PubMedGoogle Scholar
  114. 114.
    Schabel, F. M. The use of tumor growth kinetics in planning curative chemotherapy of advanced solid tumors. Cancer Res. 29, 2384. 1967.Google Scholar
  115. 115.
    Schechter, I., Wolf, O., Kantor, F., Schecher, B., Burstein, Y. Immunoglobulin precursors: structure, function, gene-protein correlation and evolution. Annals N. Y. Acad. Sci. 343, 218. 1980.CrossRefGoogle Scholar
  116. 116.
    Schultz, D. R., Yunis, A. A. Immunoblastic lymphadenopathy with mixed cryoglobulinemia. N. Eng. J. Med. 292, 8. 1975.CrossRefGoogle Scholar
  117. 117.
    Shuster, M., Causing, W. C., Young, A. Chronic lymphatic leukemia and lymphosarcoma terminating in multiple myeloma. J. Med. Soc. N. Y. 68, 365. 1971.Google Scholar
  118. 118.
    Skipper, H. E. Thoughts on cancer chemotherapy and combination modality therapy. J. Amer. Med. Ass. 230, 1033. 1974.CrossRefGoogle Scholar
  119. 119.
    Simpson-Herran, I. Lloyd, H. H. Kinetic parameters and growth curves for experimental tumor systems. Cancer Chemother. Rep. 54, 143. 1970.Google Scholar
  120. 120.
    Snapper, I., Turner, L. B., Muscovitz, H. L. Multiple myeloma. Grune et Stratton, New York. 13. 49. 104. 109. 1953.Google Scholar
  121. 121.
    Spiegelber, H. L., Heath, V. C, Lang, J. E. IgG half-molecules: clinical and immunologic features in a patient with plasma cell leukemia. Blood. 45, 305. 1975.Google Scholar
  122. 122.
    Stobbe, H. Syntropie von chronischer Lymphadenose und Plasmocytom. Acta Haematol. 27, 180. 1962.PubMedCrossRefGoogle Scholar
  123. 123.
    Sugai, S., Hirose, Y., Konaka, Y., Konda, S. Leukemic lymphosarcoma (LLS) with monoclonal IgM: Idiotypic specificity on the cell surface and in the cytoplasm of lymphosarcoma cells. Blood. 52, 922. 1978.PubMedGoogle Scholar
  124. 124.
    Sullivan, P. W., Salmon, S. E. Kinetics of tumor growth and regression in IgG multiple myeloma. J. Clin. Invest. 51, 1967. 1972.CrossRefGoogle Scholar
  125. 125.
    Teodorescu, M., Mayer, E. P. Surface immunoglobulin in immunproliferative diseases. Ann. clin. Lab. Sci. 8, 353. 1978.PubMedGoogle Scholar
  126. 126.
    Togawa, A., Inove, N., Hiyamoto, K., Hyodo, H., Namba, M. Establishment and characterization of a human myeloma cell line (KMM-1) Int. J. Cancer. 29, 495, 1982.PubMedCrossRefGoogle Scholar
  127. 127.
    Thomas, F. B., Clavsen, K. P., Greenberg, N. J. Liver disease in multiple myeloma. Arch. Intern. Med. 132, 195. 1973.PubMedCrossRefGoogle Scholar
  128. 128.
    Traganos, F., Darzynkiewicz, Z., Sharpless, T., Melamed, M.R. Simultaneous staining of ribonucleic and deoxyribonucleic acids in unfixed cells using acridine orange in a flow cytofluo-rometric system. J. Histochem. Cytochem. 25, 46. 1977.PubMedCrossRefGoogle Scholar
  129. 129.
    Vander, J. B., Johnson, H. A. Chronic lymphocytic leukemia and multiple myeloma in the same patient. Arch. intern. Med. 53, 1052. 1960.Google Scholar
  130. 130.
    Vercelli, D., Cozzolino, F., Di Guglielmo, R. A comparison of two staging systems for myeloma. Nouv. Rev. Franc. d’Hématol. 23, 107. 1981.Google Scholar
  131. 131.
    Warner, T. F. C. S., Krueger, R. G. Circulating lymphocytes and the spread of myeloma. Lancet. i. 1174. 1978.CrossRefGoogle Scholar
  132. 132.
    Watanabe, S. H., Shimosato, Y., Shimoyama, M., Minato, K. Studies with multiple markers on malignant lymphomas and lymphoid leukemias. Cancer. 50, 2372, 1982.PubMedCrossRefGoogle Scholar
  133. 133.
    Wegelius, O., Skrifvars, B., Andersson, L. Rheumatoid arthritis terminating in plasmacytoma. Acta med. scand. 187, 133. 1970.PubMedCrossRefGoogle Scholar
  134. 134.
    Wildhack, R. Über gleichzeitiges Vorkommen von Leukose und Lymphogranulomatose. Folia haemat. Neue Folge. 7, 303. 1963.Google Scholar
  135. 135.
    Willis, R. A. Solitary plasmocytoma of bone. J. Path. Bact. 53, 77. 1941.CrossRefGoogle Scholar
  136. 136.
    Willis, R. A. Pathology of tumours. Butterworth and Co., London. 106, 1948.Google Scholar
  137. 137.
    Wiltshaw, E. The natural history of extramedullary plasmacytoma and its relation to solitary myeloma of bone and myelomatosis. Medicine. 55, 217. 1976.PubMedCrossRefGoogle Scholar
  138. 138.
    Woodruff, R. K. Wadsworth, J., Malpas, J. S., Tobias, J. S. Clinical staging in multiple myeloma. Brit. J. Haematol. 42, 199. 1979.CrossRefGoogle Scholar

Copyright information

© Jákó János, Budapest 1991

Authors and Affiliations

  • János Jákó
    • 1
  1. 1.1st Department of MedicinePostgraduate Medical SchoolBudapestHungary

Personalised recommendations